{"id":"W2970358718","doi":"10.1038/s41375-019-0559-9","title":"MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Rituximab; Follicular lymphoma; Hazard ratio; Gastroenterology; Refractory (planetary science); Surgery; Oncology; Lymphoma; Confidence interval; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002122501,0.0005361581,0.001603343,0.0001844492,0.0002232232,0.0007930486,0.0004277915,0.0006003587,0.0007772241],"category_scores_gemma":[0.001215552,0.000224786,0.0008621361,0.0002100689,0.0004432969,0.0004830242,0.0002892544,0.001420303,0.0001919733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006435654,"about_ca_system_score_gemma":0.0004037667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005115421,"about_ca_topic_score_gemma":0.001744337,"domain_scores_codex":[0.9992423,0.0004585445,0.00005039554,0.00009109125,0.00005365944,0.0001041075],"domain_scores_gemma":[0.9992901,0.0002100161,0.0001924382,0.00005447053,0.0000331461,0.0002198651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8529417,0.004168291,0.01765604,0.0006442465,0.002097784,0.0001856235,0.0002682325,0.001339239,0.01838574,0.00015963,0.001639325,0.1005141],"study_design_scores_gemma":[0.4495253,0.4175373,0.114547,0.000237186,0.003090918,0.0007019576,0.000166409,0.00281524,0.005941207,0.0006649627,0.004706417,0.00006609899],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939893,0.004738861,0.00007904626,0.0002562352,0.00007510268,0.00009728254,0.0001356512,0.00002097932,0.0006075187],"genre_scores_gemma":[0.9981313,0.0007378849,0.0001336465,0.0002504962,0.00008307842,0.00007595887,0.0002690958,0.000005101278,0.0003133655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002122501,"threshold_uncertainty_score":0.01122504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0195550374906363,"score_gpt":0.2789786274909884,"score_spread":0.2594235900003521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}